SUNREST Share Price Performance
Recent SUNREST News & Updates
No updates
Sunrest Lifescience Limited Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 4.67
- Gross Margin
- 39.91%
- Net Profit Margin
- 6.00%
- Debt/Equity Ratio
- 55.7%
Sunrest Lifescience Limited Competitors
About SUNREST
- Founded
- 2017
- Employees
- 179
- CEO
- WebsiteView website
Sunrest Lifescience Limited engages in the trading, wholesale, and retail of pharmaceutical products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of distributors and resellers. Sunrest Lifescience Limited was incorporated in 2017 and is based in Ahmedabad, India.
Indian Market Performance
- 7 Days: -1.6%
- 3 Months: 3.8%
- 1 Year: -6.5%
- Year to Date: -2.0%
Over the last 7 days, the market has dropped 1.6%, driven by a loss of 2.1% in the Financials sector. The market has dropped 6.5% in the last year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading